Diagnostic platform utilizing an 18-gene test to drive personalized medicine recommendations, initially targeting breast cancer

42.2

Toggle

ALPHA SCORE

42.2

MOMENTUM

NaN

MARKET

NaN

INNOVATION

NaN

MONEY

NaN

Market Capitalisation$

Viewed

Appeared in SearchNA

Ventures > Amwise

Amwise

Diagnostic platform utilizing an 18-gene test to drive personalized medicine recommendations, initially targeting breast cancer

Partners:

Merck KGaA, Merck KGaA, Merck KGaA, Merck KGaA, Merck KGaA

View All